← Back to Nuqta Atlas
Editorially curated · sa-lifera-omics
Lifera Omics-CENTOGENE Saudi Biodatabank and Genomics Platform
Provides genomic and multi-omic testing, bioinformatics and biodatabank access for Saudi precision-health, rare-disease and screening programs.
01 / Project overview
What the record establishes.
- Geographic scope
- Saudi and GCC clinical genomics with global CENTOGENE comparison data
- Project type
- Commercial national-scale genomics and multi-omics infrastructure
- Research domain
- Rare disease, population health, clinical diagnostics and bioinformatics
- Years
- 2023–
- Lifecycle status
- active
- Status basis
- Joint venture completed on 2023-11-28; Lifera Omics has operated in Riyadh since January 2024 and maintains active service and infrastructure pages.
- Status evidence date
- 2026-08-15
- Scale
- Company-reported access to more than 60,000 Saudi patient datasets, over 70 million variants and a global base exceeding 800,000 patients.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Lifera / Public Investment Fund · CENTOGENE
- Partner organizations
- Not stated
- Organism / population
- Saudi patients and global comparator cases in the CENTOGENE biodatabank
03 / Data and access
What exists and how it can be reached.
Data types
- clinical genomic testing
- multi-omics
- variants
- phenotypes
- bioinformatics
Data access
Commercial/controlled; aggregate scale public
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
National-scale, PIF-backed genomics infrastructure with a large reported Saudi data footprint and continuing operations.
Editorial note
Commercial/infrastructure initiative rather than one recruitment cohort. Saudi dataset provenance and overlap with referral cohorts, including the Saudi Adult Genomics Group, are not disclosed.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0